Loading…
In vitro Estrogenicity of Resin Composites
Previously, we have reported that sealants incorporating bisphenol A dimethacrylate showed estrogenicity by a reporter gene assay. This study tested the hypothesis that commercial composites, which contain various monomers and additives, exhibit estrogenic activity in vitro. The estrogenic activitie...
Saved in:
Published in: | Journal of dental research 2004-03, Vol.83 (3), p.222-226 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Previously, we have reported that sealants incorporating bisphenol A dimethacrylate
showed estrogenicity by a reporter gene assay. This study tested the hypothesis that
commercial composites, which contain various monomers and additives, exhibit
estrogenic activity in vitro. The estrogenic activities
of eluates obtained from 24 composites and 18 chemicals identified from the
composites tested were examined with the use of the reporter gene assay. Among the 24
composites, 6 products were estrogenic, and among the 18 constituents, 1
photostabilizer, 2-hydroxy-4-methoxy-benzophenone (HMBP), 1 photoinitiator,
2,2-dimethoxy-2-phenyl-acetophenone (DMPA), and 1 inhibitor, 2,6-di-tert-butyl-p-cresol (BHT) had
significant estrogenic activity. The concentration of HMBP in 4 estrogenic eluates
was greater than the minimum concentration required for estrogenicity, and DMPA was
found at a higher level than the minimum estrogenic concentration in the remaining 2
estrogenic specimens. These results suggest that the observed estrogenic activity of
6 composites is associated with the elution of either HMBP or DMPA. |
---|---|
ISSN: | 0022-0345 1544-0591 |
DOI: | 10.1177/154405910408300307 |